A.F. Jones
- Clinical Biochemistry top 2%
- Advanced Glycation End Products research 9
- Behavioral Neuroscience top 5%
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 6
- Biochemistry top 5%
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection 3
-
- Lipoproteins and Cardiovascular Health 4
-
- Biochemical effects in animals 4
- Diet and metabolism studies 2
-
- Poisoning and overdose treatments 3
-
- Alcohol Consumption and Health Effects 2
- Co-authors
- John LunecA H BarnettAllister ValePaul JenningsChris FlorkowskiPaul J. ThornalleyP.E. JenningsDavid London
- Journals
- Diabetic Medicine (4 papers)Annals of Clinical Biochemistry International Journal of Laboratory Medicine (4 papers)Diabetes & Metabolic Syndrome Clinical Research & Reviews (1 paper)
- Partner nations
- United KingdomUnited States
In The Last Decade
A.F. Jones
26 papers receiving 837 citations
Peers
Comparison fields: 5 of 101
- Clinical Biochemistry 233
- Behavioral Neuroscience 80
- Endocrinology, Diabetes and Metabolism 251
- Biochemistry 84
- Pharmacology 111
Countries citing papers authored by A.F. Jones
This map shows the geographic impact of A.F. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.F. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.F. Jones more than expected).
Fields of papers citing papers by A.F. Jones
This network shows the impact of papers produced by A.F. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.F. Jones. The network helps show where A.F. Jones may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A.F. Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 16 | |
| 2 | 2009 | 35 | |
| 3 | 2006 | 1 | |
| 4 | 2003 | 3 | |
| 5 | 2002 | 53 | |
| 6 | 2001 | 13 | |
| 7 | 1999 | 17 | |
| 8 | 1997 | 68 | |
| 9 | 1994 | 13 | |
| 10 | 1993 | 87 | |
| 11 | 1992 | 9 | |
| 12 | 1992 | 20 | |
| 13 | 1990 | 129 | |
| 14 | 1989 | 106 | |
| 15 | 1989 | 35 | |
| 16 | 1988 | 20 | |
| 17 | 1988 | 9 | |
| 18 | 1987 | 148 | |
| 19 | Inhibitory effect of superoxide dismutase on fructosamine assay. | 1987 | 36 |
| 20 | Protein fluorescence and its relationship to free radical activity. | 1987 | 21 |
About A.F. Jones
A.F. Jones is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism, Pharmacology, Emergency Medicine and Behavioral Neuroscience, having authored 26 papers that have together received 884 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Lipoproteins and Cardiovascular Health (4 papers), Biochemical effects in animals (4 papers), Poisoning and overdose treatments (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Diet and metabolism studies (2 papers) and Alcohol Consumption and Health Effects (2 papers). The work is most often cited by research in Clinical Biochemistry (233 citations), Behavioral Neuroscience (80 citations), Endocrinology, Diabetes and Metabolism (251 citations), Biochemistry (84 citations) and Pharmacology (111 citations). A.F. Jones has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include John Lunec, A H Barnett, Allister Vale, Paul Jennings, Chris Florkowski, Paul J. Thornalley, P.E. Jennings, David London, J. G. Ratcliffe and R Holder. Their work appears in journals such as Diabetic Medicine, Annals of Clinical Biochemistry International Journal of Laboratory Medicine, Diabetes & Metabolic Syndrome Clinical Research & Reviews, European Journal of Vascular and Endovascular Surgery and Diabetes Obesity and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.